| Literature DB >> 27929102 |
Ines Schulthess1, Martin Gorges1, Hans-Peter Müller1, Dorothée Lulé1, Kelly Del Tredici2, Albert C Ludolph1, Jan Kassubek1.
Abstract
'Resting-state' fMRI allows investigation of alterations in functional brain organization that are associated with an underlying pathological process. We determine whether abnormal connectivity in amyotrophic lateral sclerosis (ALS) in a priori-defined intrinsic functional connectivity networks, according to a neuropathological staging scheme and its DTI-based tract correlates, permits recognition of a sequential involvement of functional networks. 'Resting-state' fMRI data from 135 ALS patients and 56 matched healthy controls were investigated for the motor network (corresponding to neuropathological stage 1), brainstem (stage 2), ventral attention (stage 3), default mode/hippocampal network (stage 4), and primary visual network (as the control network) in a cross-sectional analysis and longitudinally in a subgroup of 27 patients after 6 months. Group comparison from cross-sectional and longitudinal data revealed significantly increased functional connectivity (p < 0.05, corrected) in all four investigated networks (but not in the control network), presenting as a network expansion that was correlated with physical disability. Increased connectivity of functional networks, as investigated in a hypothesis-driven approach, is characterized by network expansions and resembled the pattern of pTDP-43 pathology in ALS. However, our data did not allow for the recognition of a sequential involvement of functional connectivity networks at the individual level.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27929102 PMCID: PMC5144012 DOI: 10.1038/srep38391
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Functional connectivity alterations in ALS.
(a) BOLD synchronization illustrated as sagittal and axial connectivity heat maps showing voxel-wise Fisher’s r-to-z transformed correlation coefficients (thresholded for |z(r)| ≥ 0.4) for which the fMRI BOLD signal was correlated with the seed-voxel in M1 (motor network, upper row), the midbrain (brainstem network, second row), ventral striatum (ventral attention network, third row), the posterior cingulate cortex (default mode network/hippocampal, fourth row), and V1 in the occipital pole (primary visual network used as reference network, bottom row) for controls (1), ALS patients cross-sectionally (2), and ALS patients measured over time (3). z(r)-values indicate the strength of correlation as an indirect measure of functional connectivity. (b) Cross-sectional analysis indicated increased functional connectivity in ALS patients (N = 71) compared with controls (N = 27). However, the default mode/hippocampal network (lfourth row) revealed, besides increased (cool colors) functional connectivity, areas of regional decrease (hot colors) of functional connectivity in the prefrontal cortex. (c) Longitudinal information indicated statistically significant increases of functional connectivity in ALS patients (N = 14) at initial (1) and follow-up MRI acquisition (2) as compared with controls, consistent with the cross-sectional data (b). Analysis in ALS patients over time revealed statistically significant clusters (voxel-wise paired t-test) indicating increased functional connectivity between initial (ALS, T) and follow-up (ALS, T) MRI measurement (3). The patterns of increasing functional connectivity presented as network expansions as illustrated by the delineations (black solid lines, a2–4, B,C) corresponding to the functional connectivity maps (i.e., networks) for controls as shown in (b[1]). (b,c1–3) Clusters indicating statistically significant group effects (p < 0.05, voxel-wise t-tests) were corrected at a 5% false discovery rate (FDR)-level with further cluster-wise correction discarding small cluster (<343 mm3). (a,b,c) All results are shown in MNI stereotaxic space (cubic 1 mm grid) overlaid on the averaged study-specific echo planar imaging (EPI) template. Slice positions in each row (a1) are identical for panels associated with the motor (upper row), brainstem (second row), ventral attention (third row), default mode/hippocampal network (fourth row), and primary visual network (reference network, bottom row), respectively.
Diffusion tensor imaging-based fiber tracing.
| Healthy controls | ALS, all, | ALS, | ALS, | |||
|---|---|---|---|---|---|---|
| Corticospinal tract | ||||||
| Corticopontine tract/corticorubral tract | ||||||
| Corticostriatal pathway | 0.195 | |||||
| Perforant pathway | 0.809 | |||||
| Corpus callosum (area 5) | 0.517 | 0.112 |
Values indicate tract-wise Fractional anisotropy (FA) and are shown as median (interquartile range), min—max.
aWilcoxon Mann-Whitney-U test refers to comparison between all ALS patients and healthy controls.
bTwo-sample Wilcoxon signed rank test refers to comparison between ALS patients at T0 (baseline) and T1 (follow-up) measurement.
cArithmetically averaged FA values for the corticopontine tract and corticorubral tract according to17.
Figure 2Correlations of motor network functional connectivity in ALS.
(a) Orthogonal slices showing heat maps of the motor intrinsic functional connectivity network for the control group (N = 56, for details see Figure 1a) and (b) its corresponding 3-D representation (yellow) together with the cortico spinal tract (CST, blue) on the averaged fractional anisotropy (FA)/(b = 0)-template on a cubic 1 mm grid in MNI stereotaxic space. (c) Most representative axial slice (z = 50) showing functional motor network in ALS patients (N = 135) and controls (N = 56), indicating network expansion in ALS predominantly towards frontal areas. (d) Primary motor cortex (M1) correlations (measured by BOLD synchronization) in ALS patients and controls as exemplified for region-to-region functional connectivity between primary motor cortex (M1) and frontal eye field (FEF), i.e. M1—FEF functional connectivity (t-test; t = 4.53, p < 0.0001). (e) Significantly reduced FA values in ALS patients compared with controls indicating microstructural impairment of the CST (Mann-Whitney-U test; z = 6.37; ***p < 0.0001) and corresponding negative correlation (Spearman rank order r = 0.24; p = 0.009; corrected) with M1—FEF functional connectivity in ALS. (f) Spearman rank order correlation (r = −0.31; p = 0.0006) of M1—FEF functional connectivity with revised ALS Functional Rating Scale (ALSFRS-R). (g) Cool color map showing significantly Spearman rank order voxel-wise correlations (p < 0.05, cluster-wise corrected) of M1 connectivity with ALSFRS-R. This pattern largely overlaps with the functional network expansion in ALS (cf. Fig. 1b, upper row), indicating that functional connectivity increases with increasing physical impairment. Delineations correspond to the motor network of the controls. (h) Damage in the CST in ALS patients worsens over time as indicated by significantly reduced FA values in ALS patients (N = 27) compared with controls (N = 56) at initial (Mann-Whitney-U test; z = 3.63; *p = 0.0003) and follow-up MRI scans (Mann-Whitney-U test; z = 4.09; **p < 0.0001) and in the comparison over time (Wilcoxon signed rank test; z = 3.19; ***p = 0.0017). (a, c, g) Results are overlaid on the study-specific EPI template (1 mm cubic grid in MNI space). Abbreviations: SMA, Somatosensory motor area; SMG, supra marginal gyrus; S2, Secondary somatosensory cortex; iFC, intrinsic functional connectivity.
Subject demographics and clinical characterization.
| Healthy controls | ALS, all, | ALS, | ALS, | Δ | | |||
|---|---|---|---|---|---|---|---|
| NA | |||||||
| 0.203 | 19 : 8 | 19 : 8 | 1.000 | ||||
| 0.054 | |||||||
| NA | NA | ||||||
| NA | NA | ||||||
| NA | NA | ||||||
| NA | NA | 0.161 |
Data are shown as median (interquartile range), min—max.
aFisher’s exact test refers to comparison between all ALS patients and healthy controls.
bTwo-sample Wilcoxon signed rank test refers to comparison between ALS patients at T0 (baseline) and T1 (follow-up) measurement.
cWilcoxon Mann-Whitney-U test refers to comparison between all ALS patients and healthy controls.
dALSFRS-R, revised ALS Functional Rating Scale (maximum score 48, falling with increasing physical impairment).
eRate of disease progression computed as (48–ALSFRS-R)/(disease duration) according to35. NA, not applicable.